Press Release - UNICEF has signed an agreement that secures supply of the MVA-BN mpox vaccine at the lowest market price and ensures access to the vaccine for 77 low- and lower-middle-income countries ...

First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

The escalating global Mpox outbreak has been met with a concerning revelation. Two distinct studies have indicated that the ...

Research shows that the effectiveness of Bavarian Nordic’s Mpox vaccine drops to undetectable levels after 6-12 months.

First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September 26, 2024 - Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with ...

Mpox, an orthopoxvirus, is spreading in Africa, necessitating immediate public health interventions and further research on ...

The vaccine bulk manufacturing is scheduled for 2025 with the delivery of the freeze-dried doses set for 2026.

Amid the rising global outbreak of Mpox, two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine ...

EU drug regulator approves use of Bavarian Nordic's mpox vaccine, Imvanex for adolescents: Copengagen, Denmark Saturday, September 21, 2024, 10:00 Hrs [IST] Bavarian Nordic A/S, a ...